Enanta Pharmaceuticals (ENTA) Minority Interest (2014 - 2015)

Enanta Pharmaceuticals (ENTA) posted Minority Interest of $164000.0 for Q4 2015, up 0.61% on a QoQ basis from $163000.0 in Q3 2015.

Enanta Pharmaceuticals (ENTA) Minority Interest (2014 - 2015) Analysis & Trends

Enanta Pharmaceuticals' Minority Interest history runs 2 years deep, the most recent figure standing at $164000.0 for Q4 2015.

Quarterly Minority Interest changed N/A year-over-year to $164000.0 in Q4 2015, while the trailing twelve-month figure through Dec 2015 was $164000.0 (changed N/A YoY) and the FY2015 annual result came in at $163000.0, down 19.31% from the prior year.
Minority Interest was $164000.0 for Q4 2015 at Enanta Pharmaceuticals, up from $163000.0 in the prior quarter.
Across five years, Minority Interest topped out at $202000.0 in Q3 2014 and bottomed at $163000.0 in Q3 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Enanta Pharmaceuticals	376.07 Mn	212.29 Mn	-

Download Data